Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) EBT Margin: 2015-2020

Historic EBT Margin for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to 52,138.20%.

  • Outlook Therapeutics' EBT Margin rose 5235567.00% to 52,138.20% in Q3 2020 from the same period last year, while for Sep 2020 it was 2,367.99%, marking a year-over-year increase of 283367.00%. This contributed to the annual value of 2,387.23% for FY2024, which is 5714.00% up from last year.
  • Latest data reveals that Outlook Therapeutics reported EBT Margin of 52,138.20% as of Q3 2020, which was up 3,579.55% from 1,416.97% recorded in Q2 2020.
  • Over the past 5 years, Outlook Therapeutics' EBT Margin peaked at 52,138.20% during Q3 2020, and registered a low of -6,298.89% during Q4 2016.
  • In the last 3 years, Outlook Therapeutics' EBT Margin had a median value of -893.79% in 2019 and averaged 4,552.15%.
  • Per our database at Business Quant, Outlook Therapeutics' EBT Margin slumped by 460,905bps in 2016 and then spiked by 5,235,567bps in 2020.
  • Outlook Therapeutics' EBT Margin (Quarterly) stood at -6,298.89% in 2016, then soared by 564,191bps to -656.99% in 2017, then slumped by 25,551bps to -912.50% in 2018, then soared by 238,183bps to 1,469.33% in 2019, then soared by 5,235,567bps to 52,138.20% in 2020.
  • Its last three reported values are 52,138.20% in Q3 2020, 1,416.97% for Q2 2020, and 2,384.96% during Q1 2020.